Key Insights
The European pharmaceutical logistics market, valued at €86.89 billion in 2025, is projected to experience robust growth, driven by several key factors. Increasing demand for pharmaceutical products, fueled by an aging population and rising prevalence of chronic diseases, necessitates efficient and reliable logistics solutions. Stringent regulatory requirements concerning temperature-sensitive drug transportation (cold chain logistics) are driving investments in advanced technologies and infrastructure. The market is segmented by transportation mode (airways, railways, roadways, seaways), product type (generic and branded drugs), operation type (cold chain and non-cold chain), and application (biopharma and chemical pharma). Growth is particularly strong in the cold chain segment due to the increasing share of biologics and other temperature-sensitive pharmaceuticals. The presence of major logistics players like DHL, FedEx, and Kuehne+Nagel, along with specialized pharmaceutical logistics providers like Eurotranspharma, fosters competition and innovation within the sector. However, challenges such as fluctuating fuel prices, geopolitical uncertainties, and the need for robust security measures to prevent drug counterfeiting and theft present potential restraints on market growth.
Europe Pharmaceutical Logistics Market Market Size (In Billion)
Geographical analysis shows that Germany, France, the United Kingdom, and Italy are leading markets within Europe, reflecting higher pharmaceutical consumption and robust healthcare infrastructure. The market is expected to maintain a Compound Annual Growth Rate (CAGR) of 3.92% from 2025 to 2033, indicating a sustained and healthy expansion. This growth will be propelled by continuous advancements in technology, including the adoption of real-time tracking and monitoring systems, improved data analytics for route optimization, and the integration of blockchain technology to enhance supply chain security and traceability. The expansion of e-commerce in the pharmaceutical sector and the rising preference for home deliveries further fuels the need for scalable and reliable logistics networks. Overall, the European pharmaceutical logistics market presents significant opportunities for established players and new entrants alike, driven by a confluence of demographic, regulatory, and technological factors.
Europe Pharmaceutical Logistics Market Company Market Share
Europe Pharmaceutical Logistics Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the Europe Pharmaceutical Logistics Market, offering invaluable insights for stakeholders across the pharmaceutical and logistics sectors. Covering the period from 2019 to 2033, with a focus on 2025, this report meticulously examines market trends, competitive dynamics, and growth opportunities. The report leverages rigorous data analysis and expert insights to deliver actionable strategies for success in this dynamic market. The total market size in 2025 is estimated at XX Million.
Europe Pharmaceutical Logistics Market Market Concentration & Innovation
The European pharmaceutical logistics market is characterized by a dynamic and moderately concentrated landscape. This ecosystem is shaped by the significant presence of established global players, including industry titans like DB Schenker, DHL, and UPS, who leverage their extensive international networks and robust infrastructure to maintain a substantial market share. Concurrently, the market is witnessing a surge in competition from agile regional providers and specialized emerging firms, particularly those focusing on advanced cold chain solutions. In 2025, the top 5 players are projected to collectively hold approximately 45% of the market share, signaling a ripe environment for both strategic consolidation and disruptive innovations that redefine logistics standards.
- Market Concentration: The market’s competitive intensity is reflected in its estimated Herfindahl-Hirschman Index (HHI) of XX, indicating a moderately concentrated market with a balanced interplay between large incumbents and specialized entrants.
- Innovation Drivers: Key catalysts for innovation include the escalating demand for sophisticated cold chain logistics to preserve the integrity of temperature-sensitive pharmaceuticals, the integration of cutting-edge technologies for real-time tracking and monitoring, and an overarching industry-wide imperative for highly efficient and secure transportation solutions.
- Regulatory Frameworks: A stringent and evolving regulatory environment, particularly concerning the transportation of temperature-sensitive drugs and the paramount importance of data security and integrity, significantly influences market operations. This necessitates substantial investment in compliant technologies, advanced infrastructure, and rigorous process management.
- Product Substitutes: While direct substitutes for highly specialized pharmaceutical logistics services are virtually non-existent, indirect competition can arise from alternative transportation modalities or strategic cost-optimization initiatives implemented by pharmaceutical manufacturers.
- End-User Trends: The transformative shift towards personalized medicine and the increasing development of specialized drug delivery systems are generating a strong demand for bespoke logistics solutions that offer uncompromising quality control and precise temperature management throughout the supply chain.
- M&A Activities: The past five years have seen a notable uptick in merger and acquisition activities, with total deal values exceeding XX Million. These strategic moves are driven by the pursuit of expanded geographical footprints, the acquisition of advanced technological capabilities, and the realization of significant economies of scale, underscoring a clear trend towards industry consolidation.
Europe Pharmaceutical Logistics Market Industry Trends & Insights
The European pharmaceutical logistics market is experiencing robust growth, driven by several key factors. The increasing prevalence of chronic diseases, aging populations, and rising healthcare expenditures are fueling the demand for pharmaceutical products, consequently boosting the need for efficient and reliable logistics solutions. The market is witnessing significant technological disruption, with the adoption of advanced technologies like blockchain for enhanced security and traceability, IoT sensors for real-time temperature monitoring, and AI-powered route optimization software enhancing efficiency. Consumer preferences are increasingly emphasizing speed, reliability, and visibility of shipments, placing pressure on logistics providers to adapt and innovate. The market's competitive landscape is dynamic, with established players constantly striving to improve their service offerings and expand their market reach. The market is expected to grow at a CAGR of XX% during the forecast period (2025-2033). Market penetration of cold chain logistics is projected to reach XX% by 2033.
Dominant Markets & Segments in Europe Pharmaceutical Logistics Market
Within the European pharmaceutical logistics market, Germany stands out as the largest and most influential market, propelled by its powerhouse pharmaceutical manufacturing sector and its highly developed, efficient logistics infrastructure. Examining the operational segments, cold chain transport commands the largest share, a testament to the critical importance of maintaining precise temperature controls for a vast array of pharmaceutical products. For transportation modes, air freight remains the preferred choice for time-sensitive and high-value shipments, ensuring rapid global distribution, while road transport is indispensable for the critical last-mile delivery, connecting manufacturers to end-users. In terms of product types, branded drugs represent a larger market share than generic drugs, primarily due to their often higher value, more complex handling requirements, and stringent delivery protocols. The biopharma segment is exhibiting a significantly faster growth trajectory compared to the chemical pharma segment, a trend directly attributable to the burgeoning development and widespread adoption of biologic drugs.
- Key Drivers for Germany: The market's dominance is underpinned by a formidable pharmaceutical manufacturing base, cutting-edge logistics infrastructure, and a supportive, stable regulatory environment conducive to growth and innovation.
- Cold Chain Transport Dominance: The paramount importance of preserving the efficacy and integrity of temperature-sensitive pharmaceutical products makes cold chain transport the largest and most critical operational segment.
- Airways Transportation Leadership: For urgent global distribution and time-critical deliveries, airways transportation is the indispensable and dominant mode, ensuring pharmaceuticals reach their destinations swiftly and reliably.
- Branded Drug Segment Prevalence: The higher value and more specialized handling requirements associated with branded pharmaceuticals contribute to their larger market share within the overall logistics landscape.
- Biopharma Segment Growth: Rapid advancements in biotechnology and the increasing market penetration of biologic drugs are fueling exceptional growth in the biopharma logistics segment.
Europe Pharmaceutical Logistics Market Product Developments
Recent product developments focus on enhancing the efficiency and security of pharmaceutical logistics. This includes the implementation of real-time tracking and monitoring systems, sophisticated temperature control solutions, and advanced packaging technologies designed to maintain product integrity during transit. The integration of blockchain technology enhances traceability and security, reducing the risk of counterfeiting and ensuring product authenticity. These advancements improve the overall efficiency and security of the supply chain, strengthening market competitiveness.
Report Scope & Segmentation Analysis
This comprehensive report meticulously segments the European pharmaceutical logistics market across several key dimensions: transportation mode (airways, railways, roadways, seaways), product type (generic and branded drugs), operation type (cold chain and non-cold chain transport), and application (biopharma and chemical pharma). Each segment is subjected to in-depth analysis, detailing its current market size, projected growth trajectories, and the prevailing competitive dynamics. This granular approach provides a holistic and nuanced understanding of the market's intricate structure. The growth forecasts presented reveal significant variations across segments, underscoring the diverse market trends. Notably, the cold chain segment is anticipated to experience substantially higher growth rates compared to the non-cold chain segment, reflecting the increasing demand for specialized handling and temperature control.
Key Drivers of Europe Pharmaceutical Logistics Market Growth
The sustained growth of the European pharmaceutical logistics market is propelled by a confluence of powerful factors. The escalating global demand for pharmaceuticals, fueled by an aging demographic and the persistent rise in chronic diseases, provides a foundational impetus. Concurrently, increasingly stringent regulatory compliance requirements are compelling logistics providers to enhance safety, security, and efficiency. Technological advancements in sophisticated tracking, real-time monitoring, and advanced temperature control systems are not only improving operational capabilities but also creating new service opportunities. Furthermore, in the wake of recent global disruptions, there is a heightened emphasis on building resilient and secure supply chains, driving investment in robust and adaptable logistics solutions.
Challenges in the Europe Pharmaceutical Logistics Market Sector
The European pharmaceutical logistics market faces several significant challenges. These include stringent regulatory compliance requirements, the increasing complexity of global supply chains leading to potential disruptions, ensuring consistent temperature control during transport across various modes and distances, high transportation costs especially for airfreight, and the need to manage risks associated with counterfeit drugs.
Emerging Opportunities in Europe Pharmaceutical Logistics Market
Significant opportunities exist in the market. These include the growth of personalized medicine, the increasing demand for specialized logistics solutions, the expansion of e-commerce and direct-to-patient drug delivery, and the adoption of innovative technologies such as AI, IoT, and blockchain to enhance efficiency, traceability, and security within the pharmaceutical supply chain.
Leading Players in the Europe Pharmaceutical Logistics Market Market
- DB Schenker
- DHL
- CSP
- 7 3 Other Companies
- United Parcel Service
- Kuehne+Nagel International AG
- FedEx
- CEVA Logistics
- Agility Logistics
- C H Robinson
- Eurotranspharma
Key Developments in Europe Pharmaceutical Logistics Market Industry
- 2022-Q4: DHL announces the expansion of its temperature-controlled logistics network in Europe.
- 2023-Q1: DB Schenker invests in advanced tracking technology to enhance supply chain visibility.
- 2023-Q3: A major pharmaceutical company merges with a specialized cold chain logistics provider. (Specific details are unavailable)
Strategic Outlook for Europe Pharmaceutical Logistics Market Market
The European pharmaceutical logistics market is poised for substantial growth and presents compelling strategic opportunities over the forecast period. The relentless pace of technological innovation, coupled with evolving regulatory landscapes that prioritize enhanced safety and efficiency, will continue to be primary growth engines. Companies that strategically invest in innovation, establish specialized expertise in complex cold chain solutions, and demonstrate an unwavering commitment to data security and end-to-end traceability are best positioned for sustained success. The burgeoning demand for personalized medicine is further expected to catalyze the creation of niche, highly customized logistics offerings, opening up new avenues for specialized providers and innovative service models.
Europe Pharmaceutical Logistics Market Segmentation
-
1. Product
- 1.1. Generic Drugs
- 1.2. Branded Drugs
-
2. Operation
- 2.1. Cold Chain Transport
- 2.2. Non-cold Chain Transport
-
3. Application
- 3.1. Biopharma
- 3.2. Chemical Pharma
-
4. Transportation
- 4.1. Airways
- 4.2. Railways
- 4.3. Roadways
- 4.4. Seaways
Europe Pharmaceutical Logistics Market Segmentation By Geography
- 1. Germany
- 2. United Kingdom
- 3. The Netherlands
- 4. France
- 5. Italy
- 6. Spain
- 7. Poland
- 8. Belgium
- 9. Sweden
- 10. Rest of Europe
Europe Pharmaceutical Logistics Market Regional Market Share
Geographic Coverage of Europe Pharmaceutical Logistics Market
Europe Pharmaceutical Logistics Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 3.92% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Demand for Over the Counter Drugs Across the European Region; Growing Manufacture Activity from Pharmaceutical Companies
- 3.3. Market Restrains
- 3.3.1. High Cost Associated with the Transportation Ordered
- 3.4. Market Trends
- 3.4.1. Biopharma Sales in Europe is Increasing
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product
- 5.1.1. Generic Drugs
- 5.1.2. Branded Drugs
- 5.2. Market Analysis, Insights and Forecast - by Operation
- 5.2.1. Cold Chain Transport
- 5.2.2. Non-cold Chain Transport
- 5.3. Market Analysis, Insights and Forecast - by Application
- 5.3.1. Biopharma
- 5.3.2. Chemical Pharma
- 5.4. Market Analysis, Insights and Forecast - by Transportation
- 5.4.1. Airways
- 5.4.2. Railways
- 5.4.3. Roadways
- 5.4.4. Seaways
- 5.5. Market Analysis, Insights and Forecast - by Region
- 5.5.1. Germany
- 5.5.2. United Kingdom
- 5.5.3. The Netherlands
- 5.5.4. France
- 5.5.5. Italy
- 5.5.6. Spain
- 5.5.7. Poland
- 5.5.8. Belgium
- 5.5.9. Sweden
- 5.5.10. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Product
- 6. Germany Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Product
- 6.1.1. Generic Drugs
- 6.1.2. Branded Drugs
- 6.2. Market Analysis, Insights and Forecast - by Operation
- 6.2.1. Cold Chain Transport
- 6.2.2. Non-cold Chain Transport
- 6.3. Market Analysis, Insights and Forecast - by Application
- 6.3.1. Biopharma
- 6.3.2. Chemical Pharma
- 6.4. Market Analysis, Insights and Forecast - by Transportation
- 6.4.1. Airways
- 6.4.2. Railways
- 6.4.3. Roadways
- 6.4.4. Seaways
- 6.1. Market Analysis, Insights and Forecast - by Product
- 7. United Kingdom Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Product
- 7.1.1. Generic Drugs
- 7.1.2. Branded Drugs
- 7.2. Market Analysis, Insights and Forecast - by Operation
- 7.2.1. Cold Chain Transport
- 7.2.2. Non-cold Chain Transport
- 7.3. Market Analysis, Insights and Forecast - by Application
- 7.3.1. Biopharma
- 7.3.2. Chemical Pharma
- 7.4. Market Analysis, Insights and Forecast - by Transportation
- 7.4.1. Airways
- 7.4.2. Railways
- 7.4.3. Roadways
- 7.4.4. Seaways
- 7.1. Market Analysis, Insights and Forecast - by Product
- 8. The Netherlands Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Product
- 8.1.1. Generic Drugs
- 8.1.2. Branded Drugs
- 8.2. Market Analysis, Insights and Forecast - by Operation
- 8.2.1. Cold Chain Transport
- 8.2.2. Non-cold Chain Transport
- 8.3. Market Analysis, Insights and Forecast - by Application
- 8.3.1. Biopharma
- 8.3.2. Chemical Pharma
- 8.4. Market Analysis, Insights and Forecast - by Transportation
- 8.4.1. Airways
- 8.4.2. Railways
- 8.4.3. Roadways
- 8.4.4. Seaways
- 8.1. Market Analysis, Insights and Forecast - by Product
- 9. France Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Product
- 9.1.1. Generic Drugs
- 9.1.2. Branded Drugs
- 9.2. Market Analysis, Insights and Forecast - by Operation
- 9.2.1. Cold Chain Transport
- 9.2.2. Non-cold Chain Transport
- 9.3. Market Analysis, Insights and Forecast - by Application
- 9.3.1. Biopharma
- 9.3.2. Chemical Pharma
- 9.4. Market Analysis, Insights and Forecast - by Transportation
- 9.4.1. Airways
- 9.4.2. Railways
- 9.4.3. Roadways
- 9.4.4. Seaways
- 9.1. Market Analysis, Insights and Forecast - by Product
- 10. Italy Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Product
- 10.1.1. Generic Drugs
- 10.1.2. Branded Drugs
- 10.2. Market Analysis, Insights and Forecast - by Operation
- 10.2.1. Cold Chain Transport
- 10.2.2. Non-cold Chain Transport
- 10.3. Market Analysis, Insights and Forecast - by Application
- 10.3.1. Biopharma
- 10.3.2. Chemical Pharma
- 10.4. Market Analysis, Insights and Forecast - by Transportation
- 10.4.1. Airways
- 10.4.2. Railways
- 10.4.3. Roadways
- 10.4.4. Seaways
- 10.1. Market Analysis, Insights and Forecast - by Product
- 11. Spain Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Product
- 11.1.1. Generic Drugs
- 11.1.2. Branded Drugs
- 11.2. Market Analysis, Insights and Forecast - by Operation
- 11.2.1. Cold Chain Transport
- 11.2.2. Non-cold Chain Transport
- 11.3. Market Analysis, Insights and Forecast - by Application
- 11.3.1. Biopharma
- 11.3.2. Chemical Pharma
- 11.4. Market Analysis, Insights and Forecast - by Transportation
- 11.4.1. Airways
- 11.4.2. Railways
- 11.4.3. Roadways
- 11.4.4. Seaways
- 11.1. Market Analysis, Insights and Forecast - by Product
- 12. Poland Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 12.1. Market Analysis, Insights and Forecast - by Product
- 12.1.1. Generic Drugs
- 12.1.2. Branded Drugs
- 12.2. Market Analysis, Insights and Forecast - by Operation
- 12.2.1. Cold Chain Transport
- 12.2.2. Non-cold Chain Transport
- 12.3. Market Analysis, Insights and Forecast - by Application
- 12.3.1. Biopharma
- 12.3.2. Chemical Pharma
- 12.4. Market Analysis, Insights and Forecast - by Transportation
- 12.4.1. Airways
- 12.4.2. Railways
- 12.4.3. Roadways
- 12.4.4. Seaways
- 12.1. Market Analysis, Insights and Forecast - by Product
- 13. Belgium Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 13.1. Market Analysis, Insights and Forecast - by Product
- 13.1.1. Generic Drugs
- 13.1.2. Branded Drugs
- 13.2. Market Analysis, Insights and Forecast - by Operation
- 13.2.1. Cold Chain Transport
- 13.2.2. Non-cold Chain Transport
- 13.3. Market Analysis, Insights and Forecast - by Application
- 13.3.1. Biopharma
- 13.3.2. Chemical Pharma
- 13.4. Market Analysis, Insights and Forecast - by Transportation
- 13.4.1. Airways
- 13.4.2. Railways
- 13.4.3. Roadways
- 13.4.4. Seaways
- 13.1. Market Analysis, Insights and Forecast - by Product
- 14. Sweden Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 14.1. Market Analysis, Insights and Forecast - by Product
- 14.1.1. Generic Drugs
- 14.1.2. Branded Drugs
- 14.2. Market Analysis, Insights and Forecast - by Operation
- 14.2.1. Cold Chain Transport
- 14.2.2. Non-cold Chain Transport
- 14.3. Market Analysis, Insights and Forecast - by Application
- 14.3.1. Biopharma
- 14.3.2. Chemical Pharma
- 14.4. Market Analysis, Insights and Forecast - by Transportation
- 14.4.1. Airways
- 14.4.2. Railways
- 14.4.3. Roadways
- 14.4.4. Seaways
- 14.1. Market Analysis, Insights and Forecast - by Product
- 15. Rest of Europe Europe Pharmaceutical Logistics Market Analysis, Insights and Forecast, 2020-2032
- 15.1. Market Analysis, Insights and Forecast - by Product
- 15.1.1. Generic Drugs
- 15.1.2. Branded Drugs
- 15.2. Market Analysis, Insights and Forecast - by Operation
- 15.2.1. Cold Chain Transport
- 15.2.2. Non-cold Chain Transport
- 15.3. Market Analysis, Insights and Forecast - by Application
- 15.3.1. Biopharma
- 15.3.2. Chemical Pharma
- 15.4. Market Analysis, Insights and Forecast - by Transportation
- 15.4.1. Airways
- 15.4.2. Railways
- 15.4.3. Roadways
- 15.4.4. Seaways
- 15.1. Market Analysis, Insights and Forecast - by Product
- 16. Competitive Analysis
- 16.1. Market Share Analysis 2025
- 16.2. Company Profiles
- 16.2.1 DB Schenker
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 DHL
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 CSP**List Not Exhaustive 7 3 Other Companie
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 United Parcel Service
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Kuehne+Nagel International AG
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 FedEx
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 CEVA Logistics
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Agility Logistics
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 C H Robinson
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Eurotranspharma
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.1 DB Schenker
List of Figures
- Figure 1: Europe Pharmaceutical Logistics Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: Europe Pharmaceutical Logistics Market Share (%) by Company 2025
List of Tables
- Table 1: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 2: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 3: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 4: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 5: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Region 2020 & 2033
- Table 6: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 7: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 8: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 9: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 10: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 11: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 12: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 13: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 14: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 15: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 17: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 18: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 19: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 20: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 21: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 22: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 23: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 24: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 25: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 26: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 27: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 28: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 29: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 30: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 31: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 32: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 33: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 34: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 35: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 36: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 37: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 38: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 39: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 40: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 41: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 42: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 43: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 44: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 45: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 46: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 47: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 48: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 49: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 50: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
- Table 51: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Product 2020 & 2033
- Table 52: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Operation 2020 & 2033
- Table 53: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Application 2020 & 2033
- Table 54: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Transportation 2020 & 2033
- Table 55: Europe Pharmaceutical Logistics Market Revenue Million Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Pharmaceutical Logistics Market?
The projected CAGR is approximately 3.92%.
2. Which companies are prominent players in the Europe Pharmaceutical Logistics Market?
Key companies in the market include DB Schenker, DHL, CSP**List Not Exhaustive 7 3 Other Companie, United Parcel Service, Kuehne+Nagel International AG, FedEx, CEVA Logistics, Agility Logistics, C H Robinson, Eurotranspharma.
3. What are the main segments of the Europe Pharmaceutical Logistics Market?
The market segments include Product, Operation, Application, Transportation.
4. Can you provide details about the market size?
The market size is estimated to be USD 86.89 Million as of 2022.
5. What are some drivers contributing to market growth?
Growing Demand for Over the Counter Drugs Across the European Region; Growing Manufacture Activity from Pharmaceutical Companies.
6. What are the notable trends driving market growth?
Biopharma Sales in Europe is Increasing.
7. Are there any restraints impacting market growth?
High Cost Associated with the Transportation Ordered.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Pharmaceutical Logistics Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Pharmaceutical Logistics Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Pharmaceutical Logistics Market?
To stay informed about further developments, trends, and reports in the Europe Pharmaceutical Logistics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence